Home » Unexpected Compound Levels Incite J&J Tylenol Recall
Unexpected Compound Levels Incite J&J Tylenol Recall
Johnson & Johnson (J&J) subsidiary McNeil Consumer Healthcare is again recalling Tylenol products, this time for higher-than-expected levels of a compound.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May